Header Logo

Connection

Gordon Sun to Bevacizumab

Back to Details
This is a "connection" page, showing publications Gordon Sun has written about Bevacizumab.
Gordon Sun
Connection Strength
0.144
Bevacizumab
  1. Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States. Am J Clin Oncol. 2018 Jan; 41(1):65-72.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.